ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity.

Cell Oncol (Dordr) · 2025 · PMC11850477 · PMID 38819630

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For every comparison, P < 0.05 was considered statistically significant and P < 0.01, highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.